666

CHONGQING GENRIX BIOPHARMACEUTICAL

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−0.45CNY
Revenue estimate
Market capitalization
‪14.59 B‬CNY
−2.50CNY
‪−801.32 M‬CNY
‪1.21 M‬CNY
‪82.77 M‬
Beta (1Y)
1.96

About CHONGQING GENRIX BIOPHARMACEUTICAL

CEO
Zhi Yuan Chang
Headquarters
Chongqing
Founded
2015
FIGI
BBG018CDC7M6
Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 688443 is 39.80 CNY — it has decreased by 2.78% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange CHONGQING GENRIX BIOPHARMACEUTICAL stocks are traded under the ticker 688443.
CHONGQING GENRIX BIOPHARMACEUTICAL is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
688443 stock is 4.07% volatile and has beta coefficient of 1.96. Check out the list of the most volatile stocks — is CHONGQING GENRIX BIOPHARMACEUTICAL there?
Yes, you can track CHONGQING GENRIX BIOPHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
688443 stock has risen by 5.37% compared to the previous week, the month change is a 1.27% fall, over the last year CHONGQING GENRIX BIOPHARMACEUTICAL has showed a 13.71% increase.
688443 net income for the last quarter is ‪−233.08 M‬ CNY, while the quarter before that showed ‪−180.09 M‬ CNY of net income which accounts for −29.42% change. Track more CHONGQING GENRIX BIOPHARMACEUTICAL financial stats to get the full picture.
No, 688443 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 688443 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHONGQING GENRIX BIOPHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
688443 reached its all-time high on Mar 14, 2024 with the price of 44.50 CNY, and its all-time low was 24.16 CNY and was reached on Jun 26, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHONGQING GENRIX BIOPHARMACEUTICAL technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHONGQING GENRIX BIOPHARMACEUTICAL stock shows the strong buy signal. See more of CHONGQING GENRIX BIOPHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CHONGQING GENRIX BIOPHARMACEUTICAL future price: according to them, 688443 price has a max estimate of 48.35 CNY and a min estimate of 48.35 CNY. Read a more detailed CHONGQING GENRIX BIOPHARMACEUTICAL forecast: see what analysts think of CHONGQING GENRIX BIOPHARMACEUTICAL and suggest that you do with its stocks.